GCVRZ
Sanofi Contingent Value Rights
GCVRZ
GCVRZ
Delisted
GCVRZ was delisted on the 3rd of March, 2020.
103 hedge funds and large institutions have $73.1M invested in Sanofi Contingent Value Rights in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 18 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
39% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 18
Holders
103
Holding in Top 10
2
Calls
$15.1M
Puts
–
Top Buyers
| 1 | +$2.73M | |
| 2 | +$295K | |
| 3 | +$65.3K | |
| 4 |
Goldman Sachs
New York
|
+$45.5K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$15.1K |
Top Sellers
| 1 | -$174K | |
| 2 | -$30K | |
| 3 | -$23.1K | |
| 4 |
MCM
Mainstay Capital Management
Grand Blanc,
Michigan
|
-$14K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$9K |